• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cisplatin metabolites: a method for their separation and for measurement of their renal clearance in vivo.

作者信息

Daley-Yates P T, McBrien D C

出版信息

Biochem Pharmacol. 1983 Jan 1;32(1):181-4. doi: 10.1016/0006-2952(83)90677-9.

DOI:10.1016/0006-2952(83)90677-9
PMID:6681958
Abstract
摘要

相似文献

1
Cisplatin metabolites: a method for their separation and for measurement of their renal clearance in vivo.顺铂代谢产物：一种体内分离及测定其肾清除率的方法。
Biochem Pharmacol. 1983 Jan 1;32(1):181-4. doi: 10.1016/0006-2952(83)90677-9.
2
The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid.
Biochem Pharmacol. 1982 Jul 1;31(13):2243-6. doi: 10.1016/0006-2952(82)90108-3.
3
The renal fractional clearance of platinum antitumour compounds in relation to nephrotoxicity.铂类抗肿瘤化合物的肾分数清除率与肾毒性的关系。
Biochem Pharmacol. 1985 May 1;34(9):1423-8. doi: 10.1016/0006-2952(85)90679-3.
4
Combining TBP-based rOFFGEL-IEF with FASP and nLC-ESI-LTQ-MS/MS for the analysis of cisplatin-binding proteins in rat kidney.采用基于 TBP 的 rOFFGEL-IEF 联合 FASP 和 nLC-ESI-LTQ-MS/MS 分析大鼠肾脏中顺铂结合蛋白。
Talanta. 2014 Mar;120:433-42. doi: 10.1016/j.talanta.2013.11.084. Epub 2013 Dec 22.
5
Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometric (LC/ESI-MS/MS) Study for the Identification and Characterization of In Vivo Metabolites of Cisplatin in Rat Kidney Cancer Tissues: Online Hydrogen/Deuterium (H/D) Exchange Study.液相色谱-电喷雾电离串联质谱法（LC/ESI-MS/MS）用于鉴定和表征大鼠肾癌组织中顺铂的体内代谢物：在线氢/氘（H/D）交换研究
PLoS One. 2015 Aug 5;10(8):e0134027. doi: 10.1371/journal.pone.0134027. eCollection 2015.
6
Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin.血浆中的顺铂代谢产物：其药代动力学及在顺铂肾毒性和抗肿瘤活性中的重要性研究
Biochem Pharmacol. 1984 Oct 1;33(19):3063-70. doi: 10.1016/0006-2952(84)90610-5.
7
Effect of cisplatin on organic ion transport in membrane vesicles from rat kidney cortex.
Cancer Treat Rep. 1985 Jul-Aug;69(7-8):875-80.
8
cis-Diamminedichloroplatinum (II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats.顺二氯二氨铂（II）在雄性和雌性大鼠的肾脏、性腺及肿瘤组织中与DNA形成加合物的情况。
Cancer Res. 1987 Feb 1;47(3):718-22.
9
A study of the protective effect of chloride salts on cisplatin nephrotoxicity.氯盐对顺铂肾毒性保护作用的研究。
Biochem Pharmacol. 1985 Jul 1;34(13):2363-9. doi: 10.1016/0006-2952(85)90795-6.
10
The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates.含羟基二硫代氨基甲酸盐对顺铂诱导的肾功能障碍的预防作用
Br J Cancer. 1991 Feb;63(2):234-6. doi: 10.1038/bjc.1991.55.

引用本文的文献

1
Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometric (LC/ESI-MS/MS) Study for the Identification and Characterization of In Vivo Metabolites of Cisplatin in Rat Kidney Cancer Tissues: Online Hydrogen/Deuterium (H/D) Exchange Study.液相色谱-电喷雾电离串联质谱法（LC/ESI-MS/MS）用于鉴定和表征大鼠肾癌组织中顺铂的体内代谢物：在线氢/氘（H/D）交换研究
PLoS One. 2015 Aug 5;10(8):e0134027. doi: 10.1371/journal.pone.0134027. eCollection 2015.
2
Organ-specific biotransformation of ormaplatin in the Fischer 344 rat.奥马铂在费希尔344大鼠体内的器官特异性生物转化
Cancer Chemother Pharmacol. 1995;36(5):439-47. doi: 10.1007/BF00686194.
3
Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.
Cancer Chemother Pharmacol. 1984;13(1):58-62. doi: 10.1007/BF00401449.
4
Cisplatinum: a review, with special reference to cellular and molecular interactions.顺铂：一篇综述，特别提及细胞与分子相互作用
Agents Actions. 1984 Dec;15(5-6):520-4. doi: 10.1007/BF01966766.
5
Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat.顺二氯二氨铂（II）（DDP）在荷瘤大鼠体内药代动力学的生理模型
J Pharmacokinet Biopharm. 1985 Feb;13(1):13-39. doi: 10.1007/BF01073654.
6
Physiological pharmacokinetic modeling of cis-dichlorodiammineplatinum(II) (DDP) in several species.顺二氯二氨铂（II）（DDP）在多个物种中的生理药代动力学建模
J Pharmacokinet Biopharm. 1986 Apr;14(2):131-55. doi: 10.1007/BF01065258.
7
A model for ultrafilterable plasma platinum disposition in patients treated with cisplatin.
Cancer Chemother Pharmacol. 1987;20(1):26-32. doi: 10.1007/BF00252955.
8
Intracellular metabolites of cisplatin in the rat kidney.大鼠肾脏中顺铂的细胞内代谢产物。
Cancer Chemother Pharmacol. 1989;24(2):73-9. doi: 10.1007/BF00263124.
9
Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck.头颈部癌患者使用顺铂治疗后，低白蛋白血症患者体内铂的分布及肿瘤浓度
Br J Clin Pharmacol. 1991 Aug;32(2):173-9. doi: 10.1111/j.1365-2125.1991.tb03878.x.
10
Platinum antitumour agents: a review of (bio)analysis.铂类抗肿瘤药物：（生物）分析综述
Pharm Weekbl Sci. 1992 Jun 19;14(3):61-77. doi: 10.1007/BF01962689.